Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Robbins Geller Rudman & Dowd LLP and Scott+Scott Attorneys at Law LLP Announce A Proposed Class Action Settlement If You Purchased or Paid for a Prescription Drug With Insurance At Walgreens from January 1, 2007 through November 18, 2024


      News provided by

      Robbins Geller Rudman & Dowd and Scott+Scott Attorneys at Law

      Dec 23, 2024, 16:00 ET

      Share this article

      Share this article


      SAN DIEGO, Dec. 23, 2024 /PRNewswire/ --

      If You Purchased or Paid for a Prescription Drug with Insurance At Walgreens,1 A Class Action Settlement Could Affect You.

      This is not a solicitation from a lawyer.

      A proposed Settlement2 has been reached in a class action lawsuit against Defendant Walgreen Co. ("Walgreens") on behalf of individuals, health insurers, and other entities who pay for prescription drugs regarding Walgreens' usual and customary pricing practices. The class action lawsuit, Russo, et al. v. Walgreen Co., No. 1:17-cv-02246 (N.D. Ill.), relates to how Walgreens determined its usual and customary prices in submitting claims for prescription reimbursement, including whether it should have considered its Prescription Savings Club ("PSC") prices in determining its usual and customary prices. Walgreens denies any wrongdoing and maintains that it correctly reported its retail prices as its usual and customary prices. The Court has not decided who is right.

      The Court has preliminarily approved the proposed Settlement. To resolve the claims, the proposed Settlement will provide for $100,000,000 to be paid by Walgreens ("Settlement Fund"). As discussed below, all Court-approved attorneys' fees and expenses, the costs of notice and administering the Settlement, service awards, and other costs will be deducted from this amount ("Net Settlement Fund"). The Net Settlement Fund will be paid to members of the Settlement Class (defined below) who submit valid claims.

      The Court has scheduled a Fairness Hearing to decide whether to approve the Settlement, the plan for allocating the Net Settlement Fund among claimants, Class Counsel's request for attorneys' fees and payment of litigation expenses out of the Settlement Fund, and the plaintiffs' request for payment of services awards. The Fairness Hearing is scheduled for September 10, 2025, at 12:15 p.m. CST, before Judge Edmond E. Chang of the U.S. District Court for the Northern District of Illinois at the United States Courthouse, 219 South Dearborn Street, Chicago, IL 60604. The time and date of the Fairness Hearing may change. For up-to-date information on the Fairness Hearing, check www.SavingsClubSettlement.com.

      Who Is Included?

      The Settlement Class is defined as follows:

      • All individuals and entities in the United States and its territories who paid, in whole or in part, at any point in time from the period January 1, 2007 through November 18, 2024 (the "Settlement Class Period"), for one or more prescription drugs from Walgreens, where prescription insurance benefits were used in filling the prescription(s).

      • The following groups are excluded from the Settlement Class: (1) Walgreens and its management and affiliates, and employees of Walgreens and its affiliates; (2) the Court, members of their immediate families, and judicial staff (but not members of the immediate families of judicial staff); (3) all pharmacy benefit managers; (4) individuals who paid for all of their prescription drugs from Walgreens during the Settlement Class Period without using insurance benefits; (5) federal and state government entities other than government-funded employee benefit plans; and (6) all individuals and entities, except for the named plaintiffs, that have sued, filed an arbitration demand, or participated in a settlement in a suit against Walgreens relating to its determination of usual and customary prices in connection with the Prescription Savings Club (this exception to the exclusion from the Settlement Class does not apply to individuals or entities that have voluntarily dismissed their claims without prejudice in any suit or arbitration).

      What Does The Class Action Settlement Provide?

      Walgreens will pay $100,000,000 into a Settlement Fund to settle all claims in the lawsuit brought on behalf of Settlement Class Members who are individuals, as well as health insurers and other entities who pay for prescription drugs, in whole or in part, for employees/beneficiaries.

      The Settlement Fund will be distributed pursuant to a Plan of Allocation and Distribution, the latest version of which can be reviewed at www.SavingsClubSettlement.com. Class Counsel will ask the Court to award attorneys' fees not to exceed 30% of the Settlement Fund, as well as out-of-pocket costs, expenses and charges not to exceed $3,000,000, and interest, as well as Service Award payments to the Plaintiffs not to exceed $5,000 to each Individual Plaintiff  and $15,000 to each Fund Plaintiff, and Notice and Administration Expenses.

      The Net Settlement Fund will be distributed to members of the Settlement Class who file valid claim forms. Payments will be calculated based on the amount a claimant paid, in whole or in part, during the Settlement Class Period for the purchase of or reimbursement for one or more prescription drugs from Walgreens, where prescription insurance benefits were used in filling the prescription(s), as described below. The precise amount that you might receive from the Net Settlement Fund will depend on how much you (and other members of the Settlement Class) paid, in whole or in part, during the Settlement Class Period for the purchase of prescription drug(s) from Walgreens, where prescription insurance benefits were used in filling the prescription(s). 

      To be entitled to a payment from the Net Settlement Fund, you must submit the Claim Form (and documentation, if required) found at www.SavingsClubSettlement.com by April 17, 2025.

      YOUR LEGAL RIGHTS AND OPTIONS IN THIS SETTLEMENT

      PARTICIPATE IN
      THE SETTLEMENT
      BY COMPLETING
      AND RETURNING A
      CLAIM FORM

      To exercise your right to obtain a share of the Net Settlement
      Fund, you will need to complete, sign, and submit a Claim
      Form (and documentation, if required) by April 17, 2025. For
      further information about whether you qualify, the payment you
      may obtain, and the documentation and data you may need to
      submit, you may access the detailed Notice at
      www.SavingsClubSettlement.com or you may access a claim
      form at www.SavingsClubSettlement.com, or you may visit
      www.SavingsClubSettlement.com, or by phone at 1-877-888-
      8386.

      EXCLUDE YOURSELF
      FROM THE
      SETTLEMENT CLASS

      If you believe you are a member of the Settlement Class, you
      may choose to exclude yourself, or "opt out," from the
      Settlement Class. If you decide to exclude yourself, you will
      not be bound by any decision in this lawsuit relating to
      Walgreens. This is the only option that allows you to ever be
      part of any lawsuit (other than this lawsuit) against Walgreens
      relating to the legal claims against Walgreens in this case. To
      exclude yourself, you will need to inform the Settlement
      Administrator of your decision by March 18, 2025, and
      provide the information set forth in the Notice found at
      www.SavingsClubSettlement.com. If the Settlement is
      approved by the Court and you do not notify the Settlement
      Administrator by the deadline of your election to "opt out" of
      the Settlement Class, you will be bound by the Settlement. If
      you opt out, you may not submit a Claim Form.

      STAY IN THE
      LAWSUIT BUT
      OBJECT TO THE
      SETTLEMENT

      If you object to all or any part of the proposed Settlement, plan
      of allocation, and/or requested attorneys' fees, expenses, or
      service awards, you may write to the Court and object. You may
      only object to the proposed Settlement, plan of allocation,
      and/or requested attorneys' fees, expenses, or service awards if
      you have not excluded yourself from the Settlement Class. Any
      objections must be submitted to the Court by March 18, 2025,
      and provide the information set forth below in the Notice found
      at www.SavingsClubSettlement.com.

      DO NOTHING

      If you are a member of the Settlement Class and do not file a
      valid claim, you will not receive any payment from the
      Settlement. Moreover, even if you do not file a valid claim,
      unless you exclude yourself from the Settlement Class, you will
      nevertheless be bound by past and any future Court rulings,
      including rulings on the Settlement, if approved, and settlement
      releases but will not be eligible to receive any payment from
      the Settlement.

      GET MORE
      INFORMATION

      If you would like to get more information about the case or the
      Settlement, you can send questions to the Settlement
      Administrator identified in this Notice.

      FOR MORE INFORMATION AND A CLAIM FORM:
      CALL: 1-877-888-8386 OR VISIT:
      WWW.SAVINGSCLUBSETTLEMENT.COM

      Inquiries, other than requests for the Notice and Claim Form, should be made to Plaintiffs' Lead Counsel:

      David Mitchell
      Arthur L. Shingler III
      Robbins Geller Rudman & Dowd LLP
      655 West Broadway, Suite 1900
      San Diego, CA 92101

      Joseph P. Guglielmo
      Erin G. Comite
      Scott+Scott Attorneys at Law LLP
      The Helmsley Building, 230 Park Ave, 24th Floor
      New York, NY 10169

       1     Walgreens includes all pharmacies owned and operated by Walgreen Co., or any of its affiliates, but only to the extent and for the time period they accepted Walgreens' PSC during the Settlement Class Period.

      2     Unless otherwise defined herein, capitalized terms shall be those defined in the Stipulation of Class Action Settlement which can be found at www.savingsclubsettlement.com.

      .

      SOURCE Robbins Geller Rudman & Dowd and Scott+Scott Attorneys at Law

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.